Investor Relations & Sustainability
+49 (0) 6172 608-2485
ir-fre@fresenius.com
Senior Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Vice President Investor Relations & Sustainability
T: +49 (0) 6172 608-5167
florian.feick@fresenius.com
Data is delayed by 15 minutes.
Share Price InformationMay 06, 2021 | Bad Homburg, Germany
Conference Call Q1 2021, Fresenius
Fresenius achieves 2020 targets and expects healthy business development in 2021 despite ongoing COVID-19 impact
Preliminary guidance for 2021 confirmed
Strategic roadmap for accelerated growth through 2023 and beyond
Group-wide initiatives to improve efficiency and profitability in preparation
Medium-term growth targets confirmed
28th consecutive dividend increase proposed
|
€ in millions |
2020 |
2019 |
Change |
Organic sales growth | Currency translation effects | Acquisitions | Divestitures | % of total sales1 |
|
Fresenius Medical Care |
17,859 | 17,477 | 2% | 3% | -3% | 3% | -1% | 49% |
|
Fresenius Kabi |
6,976 | 6,919 | 1% | 4% | -3% | 0% | 0% | 19% |
|
Fresenius Helios |
9,818 | 9,234 | 6% | 4% | -1% | 3% | 0% | 27% |
| Fresenius Vamed | 2,068 | 2,206 | -6% | -8% | 0% | 2% | 0% | 5% |
|
Total |
36,277 | 35,409 | 2% | 3% | -3% | 2% | 0% | 100 % |
1 The following description of sales relates to the respective external sales of the business segments. Consolidation effects and corporate entities are not taken into account. Therefore, aggregation to total Group sales is not possible.
Sales
€ 36277 m
+5% 1
FY/19: €35,409 m
EBIT 2
€ 4612 m
0% 1
FY/19: €4,688 m
Net Income 2, 3
€ 1796 m
-3% 1
FY/19: €1,879 m
Earnings per Share 2, 3
€ 3.22
-3% 1
FY/19: €3.37
1 In constant currency
2 Before special items
3 Net income attributable to shareholders of Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
A robot at the operating table
Midwife, a dream job
My 50 years of dialysis
In battle against the coronavirus
An almost irreplaceable organ
Living life to the fullest with dialysis
Growing up with parenteral nutrition
Paul, the four-legged therapist
The History of Dialysis
Serving patients in Swaziland
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporation
